SEC Form 4 · accession 0001261380-15-000031
IRIDEX CORP · IRIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James H Mackaness
Officer — CFO and COO
Period of report
May 20, 2015
Accepted (ET)
May 21, 2015 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2015 | M | 2,000 | $0.90 | A | 44,000 | D | |
| Common StockF1 | May 20, 2015 | S | 2,000 | $9.8045 | D | 42,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option Right to BuyF2,F3 | $0.90 | May 20, 2015 | M | 2,000 | D | — | Dec 11, 2015 | Common Stock | 2,000 | 0 | D |
Explanation of responses
- F1The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $9.75 to $9.87 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F2This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
- F3Shares subject to the option are fully vested and exercisable.